Immutep (IMMP) Return on Sales (2011 - 2017)

Immutep (IMMP) posted Return on Sales of 0.03% for Q2 2017, down 140.73% on a QoQ basis from 0.01% in Q1 2017, and up 5.0% year-over-year from 0.03% in Q2 2016.

Immutep (IMMP) Return on Sales (2011 - 2017) Analysis & Trends

Immutep's Return on Sales history runs 5 years deep, the most recent figure standing at 0.03% for Q2 2017.

  • Quarterly Return on Sales rose 5.0% year-over-year to 0.03% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 0.03% (up 1.0% YoY) and the FY2025 annual result came in at 0.06%, changed 0.0% from the prior year.
  • Return on Sales was 0.03% for Q2 2017 at Immutep, down from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.01% in Q2 2014 and bottomed at 0.08% in Q2 2016.
  • A 4-year average of 0.04% and a median of 0.04% in 2017 frame the typical range for Return on Sales.
  • Annual changes were most pronounced in 2015 — Return on Sales decreased 6 bps — and 2017, when it climbed 6 bps.
  • Immutep's Return on Sales stood at 0.01% in 2014, then slumped by 569 bps to 0.05% in 2015, then plunged by 75 bps to 0.08% in 2016, then soared by 63 bps to 0.03% in 2017.
  • Business Quant data shows IMMP's Return on Sales at 0.03% in Q2 2017, 0.01% in Q1 2017, and 0.08% in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.00%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 0.00%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.00%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 0.00%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -0.03%
Mar 31, 2017 -0.01%
Jun 30, 2016 -0.08%
Mar 31, 2016 -0.07%
Jun 30, 2015 -0.05%
Jun 30, 2014 0.01%
Jun 30, 2011 0.01%